- Sort by Sort ascending
- Job Title Sort descending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
Job Title Sort descending | Site | Location | Division | Business | Functional Area | Date Posted |
---|---|---|---|---|---|---|
Specialist | Hyderabad (Office) | India | Operations | CTS | Legal & Intellectual Property & Compl. | May 22, 2024 |
Subject Matter Expert Legal & Compliance | INSURGENTES | Mexico | Operations | CTS | Legal & Intellectual Property & Compl. | May 21, 2024 |
Manager, Innovation and Data Science ERC | Hyderabad (Office) | India | Ethics Risk & Compliance | Corporate | Legal & Intellectual Property & Compl. | May 16, 2024 |
Lead IP Transactions Counsel | Basel | Switzerland | Legal | S&L | Legal & Intellectual Property & Compl. | May 14, 2024 |
Specialist | Hyderabad (Office) | India | Operations | CTS | Legal & Intellectual Property & Compl. | May 14, 2024 |
Manager, Center of Excellence | Head Office (Japan) (Pharmaceuticals) | Japan | Ethics Risk & Compliance | Pharmaceuticals | Legal & Intellectual Property & Compl. | May 09, 2024 |
Senior Legal Counsel, Operations China | Shanghai (Shanghai) | China | Legal | Pharmaceuticals | Legal & Intellectual Property & Compl. | May 06, 2024 |
Head DPDAI China | Shanghai (Shanghai) | China | Ethics Risk & Compliance | Pharmaceuticals | Legal & Intellectual Property & Compl. | Apr 26, 2024 |
Associate Director, Global Security Investigator | East Hanover | USA | Legal | Corporate | Legal & Intellectual Property & Compl. | Apr 10, 2024 |
Compliance Sr Manager /Manger– Investigation | 上海 | China | Ethics Risk & Compliance | Ethics, Risk & Compliance | Legal & Intellectual Property & Compl. | Mar 19, 2024 |
Director, Ethics Risk & Compliance Advisor - Corporate Functions | East Hanover, NJ | USA | Ethics Risk & Compliance | Ethics, Risk & Compliance | Legal & Intellectual Property & Compl. | Mar 07, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى